Symbols / CKPT
CKPT Chart
About
No company description available for this symbol.
Fundamentals
Scroll to Statements| Sector | — | Industry | — | Market Cap | — |
| Enterprise Value | — | Income | — | Sales | — |
| Book/sh | — | Cash/sh | — | Dividend Yield | — |
| Payout | — | Employees | — | IPO | — |
| P/E | — | Forward P/E | — | PEG | — |
| P/S | — | P/B | — | P/C | — |
| EV/EBITDA | — | EV/Sales | — | Quick Ratio | — |
| Current Ratio | — | Debt/Eq | — | LT Debt/Eq | — |
| EPS (ttm) | — | EPS next Y | — | EPS Growth | — |
| Revenue Growth | — | Earnings | 2025-05-13 16:00 | ROA | — |
| ROE | — | ROIC | — | Gross Margin | — |
| Oper. Margin | — | Profit Margin | — | Shs Outstand | — |
| Shs Float | — | Short Float | — | Short Ratio | — |
| Short Interest | — | 52W High | — | 52W Low | — |
| Beta | — | Avg Volume | — | Volume | — |
| Target Price | — | Recom | — | Prev Close | — |
| Price | — | Change | — |
Valuation Models
Price estimates from analyst targets and simple models.
1. Analyst consensus
—
Mean price target
2. Current target
—
Latest analyst target
3. DCF / Fair value
—
Simplified FCF or EPS-based estimate
Ratings
No analyst ratings or price targets available.
- Checkpoint Therapeutics finalizes acquisition by Sun Pharma - Investing.com Fri, 30 May 2025 07
- Sun Pharma Pays 66% Premium in $355M Checkpoint Therapeutics Acquisition - Stock Titan Sun, 09 Mar 2025 08
- Checkpoint Therapeutics, Inc.'s (NASDAQ:CKPT) Shift From Loss To Profit - Yahoo Finance Sun, 16 Mar 2025 07
- Sun Pharma agrees to acquire Checkpoint Therapeutics - Pharmaceutical Technology Mon, 10 Mar 2025 07
- Checkpoint Therapeutics gets picked up by Sun Pharma, enjoys 60% share bump - Mugglehead Investment Magazine Mon, 10 Mar 2025 07
- Is CKPT’s growth already priced in - 2025 Big Picture & Verified Trade Idea Suggestions - mfd.ru hu, 19 Feb 2026 17
- On the heels of FDA nod for cancer drug, Sun Pharma buys Checkpoint Therapeutics for up to $416M - Fierce Pharma Mon, 10 Mar 2025 07
- Checkpoint Agrees To Sun Pharma Buyout: This Deal Suits Both Parties (NASDAQ:CKPT) - Seeking Alpha Mon, 10 Mar 2025 07
- Checkpoint Therapeutics, Inc. (NASDAQ:CKPT) stock most popular amongst individual investors who own 56%, while public companies hold 14% - Yahoo Finance Mon, 03 Feb 2025 08
- Checkpoint Therapeutics: Preparing For Cosibelimab’s Upcoming PDUFA Date (NASDAQ:CKPT) - Seeking Alpha hu, 14 Nov 2024 08
- Have Insiders Been Buying Checkpoint Therapeutics, Inc. (NASDAQ:CKPT) Shares This Year? - simplywall.st Sun, 15 Sep 2019 07
- Checkpoint Therapeutics (CKPT) Stock Price, News & Analysis - MarketBeat Wed, 22 Mar 2017 13
- FDA Approves Checkpoint Therapeutics' Skin Cancer Drug One Year After Rejection - Yahoo Finance Mon, 16 Dec 2024 08
- Checkpoint Therapeutics: Updating My Strategy After Unloxcyt's Approval (NASDAQ:CKPT) - Seeking Alpha Wed, 18 Dec 2024 08
- Checkpoint Therapeutics: A Binary Bet On FDA Approval And Cosibelimab's Market Success - Seeking Alpha ue, 27 Aug 2024 07
Insider Transactions
No recent insider transactions.
Financials
No financial statements available. Data is sourced from Yahoo Finance and cached; historical storage may be added later.
SEC Filings
No SEC filings found for this symbol (may be non-US or ticker not in SEC index).
Public Trades for CKPT
| Date | User | Asset | Broker | Type | Position Size | Entry Price | Patterns |
|---|